comprehensive -WSS

comprehensive

author：leisure time 2025-09-06 01:58:54 - browse：357

WASHINGTON, DC - NOVEMBER 27: U.S. President Joe Biden speaks about supply chain resilience during an event in the Indian Treaty Room at the Eisenhower Executive Office Building on November 27, 2023 in Washington, DC. — President Biden spoke about supply chain resilience and drug shortages. Alex Wong/Getty Images

WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production won’t expand the supply of the chemotherapies that are currently in shortage, an administration official confirmed. The limited scope surprised experts, who told STAT Biden could have included those drugs in the effort.

The 15 cancer drugs in short supply account for only a little more than 10% of the drugs on FDA’s shortage list. But chemotherapies are far more crucial than many other drugs experiencing shortages, which include injections of amino acids and multivitamins, and sterile water. Gut-wrenching stories about cancer patients being switched to less-effective drugs have caused cancer doctors to agitate for government solutions.

Biden announced last week that he plans to use the Defense Production Act to get companies to make essential medicines and their ingredients in the United States. The administration will spend $35 million to boost domestic production of key starting materials for drugs that hospitals commonly use and are prone to shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： After a drawn out lobbying fight, ARPA

WSS

FDA seeks to regulate lab

Menendez indictment could see pharma lose a key ally

Life sciences deals on track to hit lowest point since 2017

Mindstrong's demise and the future of mental health care

Intercept Pharmaceuticals sells itself for less than $1 billion

Data show record exodus of life scientists from academia

hotspot

comprehensive

focus

Novavax promises a turnaround & Lilly roils the obesity market

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Wildfire smoke exposes gaps in outdoor worker protections

Inequities make cancer less preventable for women: report

Dobbs anniversary: the lost opportunity of abortion as health care

What's changing in Medicare's open enrollment this year?

As demand for Covid shots wanes, Moderna seeks its next success

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Dobbs anniversary: the lost opportunity of abortion as health care

Akero's treatment for NASH falls short in cirrhosis study

knowledge

What's changing in Medicare's open enrollment this year?

Peter Marks talks Operation Warp Speed for Rare Diseases

Better Therapeutics data on benefit with GLP

Cancer cells are shown to suck energy source from immune cells

What's changing in Medicare's open enrollment this year?

Senator probes 340B programs at Cleveland Clinic, Bon Secours

hotspot

hotspot

focus

focus